Litcius/Paper detail

Long-term safety and efficacy of safinamide as add-on therapy in levodopa-treated Japanese patients with Parkinson's disease with wearing-off: Results of an open-label study

Yoshio Tsuboi, Nobutaka Hattori, Akihiko Yamamoto, Yuji Sasagawa, Masahiro Nomoto

2020Journal of the Neurological Sciences23 citationsDOIOpen Access PDF

Topics & Concepts

DiscontinuationMedicineLevodopaParkinson's diseaseAdverse effectInternal medicineClinical endpointRating scaleDiseaseClinical trialPsychologyDevelopmental psychologyParkinson's Disease Mechanisms and TreatmentsParkinson's Disease and Spinal DisordersNeurological disorders and treatments
Long-term safety and efficacy of safinamide as add-on therapy in levodopa-treated Japanese patients with Parkinson's disease with wearing-off: Results of an open-label study | Litcius